CEGID
24.4.2024 15:37:29 CEST | Business Wire | Press release
Cegid, a European leader in cloud business management solutions for finance (treasury, tax, ERP), human resources (payroll, talent management), CPAs, retail and entrepreneurial sectors, strengthens its position in the fast-growing sector of invoicing and accounting software solutions for the Micro and SMB segments through the potential acquisition of EBP, one of the leading enterprise software providers in this market segment. Following Cegid’s investments in Iberia and Belgium, this major step will allow the new Cegid Group to become the leader in this high-growth market segment ahead of the implementation of mandatory e-invoicing.
EBP, established as one of the leading solutions providers in France known for its long-standing expertise in working with Micro and SMB businesses, its user-centered approach and its distinctive know-how, has been serving its customer base of 275,000 companies using its solutions in France for close to 40 years.
The acquisition of EBP represents a major strategic milestone for Cegid, enabling Cegid to extend its offering with a range of invoicing, business management and accounting software tailored to meet the needs of Micro and SMB businesses in France, including in specific verticals such as construction and automotive. With its existing footprint in Iberia and Belgium, this opportunity also allows Cegid to strengthen its European leadership with this new position in the French market.
“With the acquisition of EBP, we are accelerating our European strategy in serving small businesses, one of Cegid’s five priority markets. By combining our two companies, EBP and Cegid, we become a leader with annual revenue close to one billion euros and serving close to 750,000 customers. Our shared vision, the strength of our two brands, the performance of the combined product portfolio, our innovation in emerging technologies such as artificial intelligence, our culture centered around co-creation and entrepreneurship, and the talent within our teams create a unique opportunity. Through this collaboration, we will meet the needs of small businesses directly or through the network of 440 partners built by EBP; most importantly, we will enable chartered accountants to strengthen their strategic position with French Micro and SMB businesses by offering them a wide range of innovative and purposeful business solutions. Cegid will thus become the software provider of choice for Micro and SMBs, supporting the digitalisation of the economy by facilitating compliance in a changing regulatory landscape including the advent of mandatory electronic invoicing, and ultimately enabling their growth through solutions that are unique in the market,” said Pascal Houillon, CEO of Cegid.
With a track-record of sustained growth, EBP will find in Cegid and its majority shareholder Silver Lake a major ally to finance and structure its next phase of expansion, notably accelerating the transition to SaaS and the integration of generative artificial intelligence technology to better serve current and future clients.
“As a shareholder, Silver Lake is very pleased to continue promoting Cegid’s development. The growth potential of the small business software market is significant in Europe as a whole, and particularly in France where the introduction of electronic invoicing for all businesses is imminent. With the addition of EBP, we are accelerating Cegid's strategy in the Micro and SMB markets across the continent while starting a new phase of sustainable growth over the next decade. The quality of EBP's solutions combined with Cegid's footprint among chartered accountants make for a perfect combination in this high-potential market,” said Christian Lucas, Managing Partner of Silver Lake and Vice-Chairman of Cegid Group’s Board of Directors.
Founder René Sentis, Deputy Chief Executive Officer Grégoire Leclercq and his management team as well as EBP's 650 employees will join Cegid in the coming weeks.
“The timing of this combination could not be better for EBP's development. With nearly 40 years of significant growth, and now more motivated than ever to support our customers in their digital transformation journey and to prepare for the upcoming e-invoicing regulation, we are thrilled to be joining forces with Cegid. The company's strength, its expertise in cloud technologies, its recent announcements around offering a free PDP solution and the Cegid Business solution as part of the e-invoicing, as well as its investments in artificial intelligence will all be instrumental for EBP. Synergies resulting from this combination are evident with respect to both our product portfolios and Cegid’s footprint with CPAs, as well as financing solutions that we can offer to our clients – our conviction in this partnership is unwavering, and we are committed to reinvesting significantly in this combined group. Additionally, this is a great opportunity to accelerate the development of EBP’s recently launched Hubbix platform. With Cegid, we are proud to embark on this exciting journey to better serve our clients and conquer new markets together,” concludes René Sentis, Founder & CEO of EBP.
As is customary, the transaction remains subject to the approval of relevant regulatory authorities and to the information and consultation processes of representative bodies of staff concerned, in accordance with applicable laws.
More information:
About Cegid
Cegid is a European leader in cloud business management solutions for finance (cash-flow, tax, ERP), human resources (payroll, talent management), CPAs, retail and entrepreneurial sectors. With a solid full cloud business model, Cegid provides long-term commitment to its customers, superior and distinctive experiences and helps companies of all sizes accelerate their digital business transformation, locally and worldwide. Cegid combines a forward-thinking and pragmatic approach of the business with strong capacity to innovate, an in-depth expertise in new technologies such as artificial intelligence and an understanding of regulations and compliance. In today’s rapidly changing world, Cegid makes more possible by helping customers unleash their potential thanks to innovative and purposeful business solutions.
Bolstered by its strong international ambition and reach, and its 500,000 customers, Cegid has 4,400 employees and sells its solutions in 130 countries. Cegid reported revenues of €852 million (as of December 31 2023). Pascal Houillon has been the CEO since March 2017.
For more information: www.cegid.com/en/
About EBP
For 40 years, EBP supports the success and longevity of 275 000 Micro and SMBs, maintaining relationships founded on trust. The company offers solutions across France, Spain, Switzerland, Morocco and Ivory Coast, leveraging its extensive portfolio of innovative accounting, business management, HCM and CRM products tailored to SMBs, freelancers, retailers and independent professionals.
More information: EBP • Logiciels et solutions de gestion et de comptabilité and social networks
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240424304702/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom